P. López-Serrano

发表

Outcomes of Pregnancies Fathered by Inflammatory Bowel Disease Patients Exposed to Thiopurines

J. Gisbert, A. Muriel, C. Taxonera, 2010, The American Journal of Gastroenterology.

Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: A Spanish case–control study

C. Fernández-Rodríguez, J. Pérez-Calle, P. López-Serrano, 2010, Scandinavian journal of gastroenterology.

Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid.

C. Fernández-Rodríguez, J. Pérez-Calle, P. López-Serrano, 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.

J. Gisbert, R. García-Castellanos, M. Chaparro, 2012, Journal of Crohn's & colitis.

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease

J. Gisbert, M. Chaparro, S. Riestra, 2018, Journal of Crohn's & colitis.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

J. Gisbert, X. Calvet, M. Piqueras, 2019, Journal of Crohn's & colitis.

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

V. Soriano, P. López-Serrano, A. Mariño, 2008, AIDS.

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

J. Gisbert, M. Chaparro, S. Riestra, 2017, Journal of Crohn's & colitis.

Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

J. Pérez-Calle, P. López-Serrano, C. Rodríguez, 2015, World journal of hepatology.

Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

J. Pérez-Calle, P. López-Serrano, M. D. Sánchez-Tembleque, 2013, World journal of gastroenterology.

Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.

J. Gisbert, M. Chaparro, J. Mendoza, 2016, Journal of Crohn's & colitis.

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

J. Gisbert, E. Savarino, A. Shitrit, 2018, The American Journal of Gastroenterology.

Incidence, management, and course of cancer in patients with inflammatory bowel disease.

M. Chaparro, C. Taxonera, A. López-Sanromán, 2015, Journal of Crohn's & colitis.

Ulcerative colitis in Madrid, Spain: current management.

C. Fernández-Rodríguez, J. Pérez-Calle, P. López-Serrano, 2010, Inflammatory bowel diseases.

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

J. Gisbert, E. Martí-Bonmatí, X. Calvet, 2017, Journal of Crohn's & colitis.

Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.

F. Mesonero, F. Bermejo, A. Algaba, 2021, Inflammatory bowel diseases.

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

R. Andrade, M. Diago, J. Salmerón, 2005, Gastroenterology.

[Effect of pentoxifylline on survival, cardiac function and both portal and systemic hemodynamics in advanced alcoholic cirrhosis--a randomized double-blind placebo-controlled trial].

C. Fernández-Rodríguez, P. López-Serrano, M. Pérez-Fernández, 2008, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Long‐term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype

C. Fernández-Rodríguez, J. Pérez-Calle, P. López-Serrano, 2006, Alimentary pharmacology & therapeutics.

P651 Identification of new genetic variants related to thiopurine-induced myelotoxicity in inflammatory bowel disease (IBD) patients with normal thiopurines-methyltransferase (TPMT): a genome-wide association study

J. Gisbert, A. González-Neira, G. Pita, 2013 .

Epidemiological Study of Perianal Fistulas in Patients With Crohn's Disease

J. Mate, J. Gisbert, M. Chaparro, 2011 .

Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain.

J. Pérez-Calle, P. López-Serrano, L. Menchen, 2020, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation

J. Gisbert, X. Calvet, D. Busquets, 2017, Digestive Diseases and Sciences.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

J. Gisbert, D. Busquets, A. Gutiérrez, 2017, Inflammatory bowel diseases.

Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.

F. Mesonero, F. Bermejo, A. Algaba, 2021, Inflammatory bowel diseases.

548 Sustained response in chronic hepatitis C reduces the risk to develop impaired fasting glucose and/or diabetes mellitus type 2

M. Diago, C. Fernández-Rodríguez, P. López-Serrano, 2006 .

W1313 Adalimumab for Luminal and Perianal Crohn's Disease in Real Practice: A Long-Term Multicenter Study of Effectiveness, Safety and Predictors of Response

J. Gisbert, M. Chaparro, A. Román, 2010 .

Prevalence of Macrocreatinkinase Type 1 in Patients with Inflammatory Bowel Disease

J. Gisbert, A. Peña, C. Fernández-Rodríguez, 2008, Digestive Diseases and Sciences.